Corrigendum to “Tumorigenicity of IL-1α- and IL-1β-Deficient Fibrosarcoma Cells” [Neoplasia, Volume 10, Issue 6, June 2008, Pages 549–562]
Irina Nazarenko,
Rachid Marhaba,
Eli Reich,
Elena Voronov,
Mario Vitacolonna,
Dagmar Hildebrand,
Elena Elter,
Mohini Rajasagi,
Ron N. Apte,
Margot Zöller
Affiliations
Irina Nazarenko
Department of Tumor Progression and Tumor Defense, German Cancer Research Center Heidelberg, Germany
Rachid Marhaba
Department of Tumor Progression and Tumor Defense, German Cancer Research Center Heidelberg, Germany
Eli Reich
The Shraga Segal Department of Microbiology and Immunology and the Cancer Center, Ben Gurion University Beer-Sheva, Israel
Elena Voronov
The Shraga Segal Department of Microbiology and Immunology and the Cancer Center, Ben Gurion University Beer-Sheva, Israel
Mario Vitacolonna
Department of Tumor Progression and Tumor Defense, German Cancer Research Center Heidelberg, Germany
Dagmar Hildebrand
Department of Tumor Progression and Tumor Defense, German Cancer Research Center Heidelberg, Germany
Elena Elter
Department of Tumor Progression and Tumor Defense, German Cancer Research Center Heidelberg, Germany
Mohini Rajasagi
Department of Tumor Progression and Tumor Defense, German Cancer Research Center Heidelberg, Germany
Ron N. Apte
The Shraga Segal Department of Microbiology and Immunology and the Cancer Center, Ben Gurion University Beer-Sheva, Israel
Margot Zöller
Department of Tumor Progression and Tumor Defense, German Cancer Research Center Heidelberg, Germany; Department of Applied Genetics, University of Karlsruhe. Karlsruhe, Germany
